Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05285735 · ClinicalTrials.gov registry record
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
A clinical trial of Pregnancy and Malaria, sponsored by Amivas.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT05285735: Recruiting study of Pregnancy and Malaria, sponsored by Amivas.
NCT05285735 is a study of Pregnancy and Malaria that is actively recruiting participants, run by Amivas. The registered enrollment target is 25 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05285735, a study of Pregnancy and Malaria, is actively recruiting participants, sponsored by Amivas.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Primary Outcome
Number of pregnant females with high blood pressure reported in medical record
Study Locations (1)
New Jersey
- 4C Pharma Solutions - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-06-08 |
| Est. Completion | 2029-07-01 |
What NCT05285735 shows while recruiting
NCT05285735 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT05285735 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05285735 about?
NCT05285735 is a clinical study titled "Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants". This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child'...
What is the current status of trial NCT05285735?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2022-06-08. Estimated completion is 2029-07-01.
What conditions does trial NCT05285735 study?
This clinical trial studies the following conditions: Pregnancy, Malaria.
Who is sponsoring clinical trial NCT05285735?
This trial is sponsored by Amivas, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05285735 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05285735's enrollment target sits among peer trials
25 176th of 191 higher than 14 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI